| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5826613 | Current Opinion in Pharmacology | 2007 | 6 Pages |
Abstract
Immunomodulation in infectious diseases, cancer, cardiovascular disease and autoimmunity can now be targeted by sophisticated protein design, altering cellular responses by increasing therapeutic cell numbers ex vivo and then reimplanting, or altering cell function by gene transfer of cells ex vivo. In the last year, vaccination has been applied to modulate responses to autoantigens, allergens, viral or cancer antigens. The application of these technologies has entered the clinical arena and is having a positive impact on the treatment and prevention of human diseases.
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
David J Gould, Yuti Chernajovsky,